# Acceptability of Depo-subQ Provera 104 in Uniject vs. Intramuscular Depo-Provera Among HIV+ Women & Providers, Uganda

> **NCT01578447** · NA · COMPLETED · sponsor: **Johns Hopkins Bloomberg School of Public Health** · enrollment: 356 (actual)

## Conditions studied

- Acceptability of Different Contraceptive Injection Types

## Interventions

- **DRUG:** DepoSubQ Provera 104 in Uniject
- **DRUG:** Intramuscular DMPA

## Key facts

- **NCT ID:** NCT01578447
- **Lead sponsor:** Johns Hopkins Bloomberg School of Public Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 356 (ACTUAL)
- **Last updated:** 2014-09-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01578447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01578447, "Acceptability of Depo-subQ Provera 104 in Uniject vs. Intramuscular Depo-Provera Among HIV+ Women & Providers, Uganda". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01578447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*